
Current Clinical Data in HRPCI
This series of courses reviews the clinical evidence pathway to a Class I recommendation for Protected PCI including: a) the PROTECT studies (I, II, III) and the rationale for PROTECT IV; b) renal protection data; c) bailout data; and d) ejection fraction improvement data.
Course Outline 1:09:19
Introduction to CAMP
32:23
Clinical Evidence Pathway to Class I Recommendation for High-Risk PCI
7:32
Emerging Data on Renal Protection Using Impella Support
10:34
Evaluating Bailout Impella Use in High-Risk PCI
7:03
Rationale for PROTECT IV
11:47